Rallying on Street: Special Research on Dick's Sporting, Monsanto, Halozyme, Janus Capital and Sony

NEW YORK, January 8, 2015 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including Dick's Sporting (NYSE: DKS), Monsanto (NYSE: MON), Halozyme (NASDAQ: HALO), Janus Capital (NYSE: JNS), and Sony (NYSE: SNE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.


Today's update concerns the following companies:


Full PDF Download Links (you may have to copy and paste the following links into your browser):

DKS Research Report: ( http://get.analystsreview.com/pdf/?c=Dick%27s%20Sporting&d=08-Jan-2015&s=DKS ),

MON Research Report: ( http://get.analystsreview.com/pdf/?c=Monsanto&d=08-Jan-2015&s=MON ),

HALO Research Report: ( http://get.analystsreview.com/pdf/?c=Halozyme&d=08-Jan-2015&s=HALO ),

JNS Research Report: ( http://get.analystsreview.com/pdf/?c=Janus%20Capital&d=08-Jan-2015&s=JNS ),

SNE Research Report: ( http://get.analystsreview.com/pdf/?c=Sony&d=08-Jan-2015&s=SNE ).



Analyst Update: Acquisition Speculations,Quarterly Earnings, Study Results, and Analyst Upgrade

Reviewed by: Rohit Tuli, CFA®  

The Wall Street finally witnessed a rebound on Wednesday, January 7, as slight recovery in the oil prices coupled with latest data on the U.S. economy boosted sentiments in equities. The latest FOMC meeting minutes, which signaled that the U.S. central bank may refrain from raising interest rates until at least end of April, also helped U.S. stocks rally the most in three weeks on Wednesday. Snapping the five-day long losing streak, the S&P 500 index marked its first gain in 2015 and ended the session higher by 1.16% at 2,025.90. Similarly, the Dow Jones Industrial Average rose 1.23% to finish at 17,584.52, and the NASDAQ Composite ended higher by 1.26% at 4,650.47. A recent report on the health of the U.S. economy said that companies in the U.S. added 241,000 workers in December, the highest since June. European markets also had a sigh of relief on Wednesday after a drop in euro area consumer prices in December lifted hopes that ECB will launch further stimulus soon. Most Asian markets also ended higher on Wednesday tracking strong global cues.

Dick's Sporting Goods, Inc.'s (Dick's Sporting) shares jumped over 11% on Wednesday, January 7, amid speculations that the sporting goods retailer is holding early-stage conversations with a handful of buyout firms about going private. According to a Reuters report, the Company has been pegged as a potential buyout target by analysts, partly due to its share performance that lagged peers. For additional details on this latest speculation doing rounds on the Wall Street, please visit our exclusive research report.

Monsanto Company (Monsanto) reported first quarter fiscal 2015 earnings that beat the market expectations, helped by strength in its soybean-seed segment. Monsanto also confirmed its fiscal year 2015 ongoing EPS guidance, but warned that lower U.S. corn acreage would hurt its bottom-line in the second quarter. Read more on Monsanto's financial performance in first quarter in our exclusive research report.

Halozyme Therapeutics, Inc. (Halozyme) discussed interim results from a Phase 2 study of its investigational new drug PEGPH20 with analysts and investors in New York on Wednesday, demonstrating its potential to treat a range of solid tumors with accumulation of high levels of hyaluronan (HA). Know more about the Company's R&D activities in our exclusive research report.

Janus Capital Group, Inc. (Janus Capital) continues its bull run in 2015 as the stock soared nearly 5% on Wednesday, January 7, after JPMorgan upgraded the Denver-based asset management company to "overweight" from "underweight" with a price target of $20. Read our exclusive research report to find out what has led analysts upgrade Janus Capital.

Sony Corp.'s (Sony) CEO Kazuo Hirai has said that the November cyber-attack on Sony Pictures will not have any significant financial impact. Speaking to the reporters at the Consumer Electronics Show in Las Vegas, Hirai also said that the Company continues to review the effects of the cyber-attack, which was aimed at preventing the release of film "The Interview". Read more about the story as Sony CEO breaks his silence about the hacking incident in our research report.


About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.


Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.